Chemoinformaics analysis of (3E)-2-methyl-6-methylideneocta-3,7-dien-2-ol
| Molecular Weight | 152.237 | nRot | 4 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 18 |
| Exact Molecular Weight | 152.12 | nRing | 0 |
| Solubility: LogS | -3.593 | nHRing | 0 |
| Solubility: LogP | 2.075 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.572 |
| Synth | 2.675 |
| Natural Product Likeliness | 1.525 |
| NR-PPAR-gamma | 0.871 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.841 |
| HIA | 0.018 |
| CACO-2 | -5.112 |
| MDCK | 0.00000705 |
| BBB | 0.007 |
| PPB | 0.934889 |
| VDSS | 0.599 |
| FU | 0.0663039 |
| CYP1A2-inh | 0.964 |
| CYP1A2-sub | 0.757 |
| CYP2c19-inh | 0.11 |
| CYP2c19-sub | 0.047 |
| CYP2c9-inh | 0.628 |
| CYP2c9-sub | 0.847 |
| CYP2d6-inh | 0.712 |
| CYP2d6-sub | 0.295 |
| CYP3a4-inh | 0.526 |
| CYP3a4-sub | 0.072 |
| CL | 7.372 |
| T12 | 0.905 |
| hERG | 0.085 |
| Ames | 0.206 |
| ROA | 0.218 |
| SkinSen | 0.936 |
| Carcinogencity | 0.041 |
| EI | 0.94 |
| Respiratory | 0.159 |
| NR-Aromatase | 0.653 |
| Antiviral | No |
| Prediction | 0.946989 |